NASDAQ:TLRYTilray Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Tilray Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $8.13 +0.28 (+3.57 %) (As of 07/7/2020 10:56 AM ET) Add Compare Share Today's Range$7.80Now: $8.13▼$8.3850-Day Range$6.96MA: $8.84▼$10.8152-Week Range$2.43Now: $8.13▼$48.48Volume111,715 shsAverage Volume6.82 million shsMarket Capitalization$1.02 billionP/E RatioN/ADividend YieldN/ABeta3.25 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSocial Media Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.Read More Beat the Market (BTM) Rank™ 4.0 Analyst's Opinion Consensus RatingTilray has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 12 hold ratings, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.77, Tilray has a potential upside of 57.5% from its current price of $8.11.Amount of Analyst CoverageTilray has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.3 Community Rank Outperform VotesTilray has received 424 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTilray has received 487 “underperform” votes. (Add your “underperform” vote.)Community SentimentTilray has received 53.46% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Tilray and other stocks. Vote “Outperform” if you believe TLRY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TLRY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTilray does not currently pay a dividend.Dividend GrowthTilray does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Tilray insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,471,842.00 in company stock.Percentage Held by InsidersOnly 16.75% of the stock of Tilray is held by insiders.Percentage Held by InstitutionsOnly 7.94% of the stock of Tilray is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Tilray are expected to grow in the coming year, from ($0.90) to ($0.65) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tilray is -1.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tilray is -1.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTilray has a P/B Ratio of 2.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 4.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.39 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TLRY Previous Symbol CUSIPN/A CIKN/A Webwww.tilray.com Phone206-432-9325Debt Debt-to-Equity Ratio2.63 Current Ratio1.98 Quick Ratio1.42Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$166.98 million Price / Sales6.08 Cash FlowN/A Price / Cash FlowN/A Book Value$2.78 per share Price / Book2.92Profitability EPS (Most Recent Fiscal Year)($1.69) Net Income$-321,170,000.00 Net Margins-241.79% Return on Equity-62.82% Return on Assets-20.28%Miscellaneous Employees1,646 Outstanding Shares124,860,000Market Cap$1.02 billion Next Earnings Date8/11/2020 (Estimated) OptionableOptionable NASDAQ:TLRY Rates by TradingView Receive TLRY News and Ratings via Email Sign-up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter. Tilray (NASDAQ:TLRY) Frequently Asked Questions How has Tilray's stock been impacted by COVID-19 (Coronavirus)? Tilray's stock was trading at $7.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TLRY stock has increased by 14.4% and is now trading at $8.11. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Tilray? 16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last year. There are currently 2 sell ratings, 12 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Tilray. When is Tilray's next earnings date? Tilray is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Tilray. How were Tilray's earnings last quarter? Tilray Inc (NASDAQ:TLRY) posted its quarterly earnings results on Monday, May, 11th. The company reported ($1.73) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.44) by $1.29. The company earned $52.20 million during the quarter, compared to analysts' expectations of $49.37 million. Tilray had a negative return on equity of 62.82% and a negative net margin of 241.79%. The company's revenue for the quarter was up 127.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.27) earnings per share. View Tilray's earnings history. What price target have analysts set for TLRY? 16 brokerages have issued 12-month price objectives for Tilray's shares. Their forecasts range from $4.00 to $31.00. On average, they anticipate Tilray's share price to reach $12.77 in the next year. This suggests a possible upside of 57.5% from the stock's current price. View analysts' price targets for Tilray. Has Tilray been receiving favorable news coverage? News headlines about TLRY stock have been trending negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Tilray earned a daily sentiment score of -2.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Tilray. Who are some of Tilray's key competitors? Some companies that are related to Tilray include Cronos Group (CRON), USANA Health Sciences (USNA), Aurora Cannabis (ACB), Aphria (APHA), Canopy Rivers (RIV), Chromadex (CDXC), Mediwound (MDWD), Sundial Growers (SNDL), Happiness Biotech Group (HAPP), Natural Alternatives International (NAII), Mannatech (MTEX), Cyanotech (CYAN), FitLife Brands (FTLF), True Drinks (TRUU) and GLG Life Tech (GLGLF). View all competitors. What other stocks do shareholders of Tilray own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), Advanced Micro Devices (AMD), Aphria (APHA) and Square (SQ). Who are Tilray's key executives? Tilray's management team includes the following people: Mr. Edward Wood Pastorius Jr., Chief Revenue Officer (Age 50)Mr. Brendan Kennedy, Pres, CEO & Director (Age 46)Mr. Mark Castaneda, CFO, Sec. & Treasurer (Age 53)Dr. Catherine Jacobson, Director of Clinical Research & Member of Medical Advisory Board When did Tilray IPO? (TLRY) raised $135 million in an initial public offering on Thursday, July 19th 2018. The company issued 9,000,000 shares at a price of $14.00-$16.00 per share. Cowen and Company served as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers. What is Tilray's stock symbol? Tilray trades on the NASDAQ under the ticker symbol "TLRY." How do I buy shares of Tilray? Shares of TLRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Tilray's stock price today? One share of TLRY stock can currently be purchased for approximately $8.11. How big of a company is Tilray? Tilray has a market capitalization of $1.01 billion and generates $166.98 million in revenue each year. The company earns $-321,170,000.00 in net income (profit) each year or ($1.69) on an earnings per share basis. Tilray employs 1,646 workers across the globe. What is Tilray's official website? The official website for Tilray is www.tilray.com. How can I contact Tilray? Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The company can be reached via phone at 206-432-9325. This page was last updated on 7/7/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
